Hyperbaric oxygen in the treatment of gas gangrene and perineal necrotizing fasciitis: a clinical and experimental study | Canada Hyperbarics Skip to main content
Clinical Study Eur J Surg Suppl 1993

Hyperbaric oxygen in the treatment of gas gangrene and perineal necrotizing fasciitis: a clinical and experimental study

Hirn M, Niinikoski J, Lehtonen OP. — Eur J Surg Suppl, 1993

Tier 1, Curated

Manually reviewed and included in the Canada Hyperbarics research database.

Summary

What Researchers Did

Researchers investigated the outcomes of 32 patients with gas gangrene and 11 patients with perineal necrotizing fasciitis who received hyperbaric oxygen therapy in addition to standard treatments like surgery and antibiotics.

What They Found

Among 32 patients with clostridial gas gangrene, the overall mortality rate was 28%, with 6 of 17 patients with myonecrosis and 3 of 15 patients with cellulitis dying. For the 11 patients with perineal necrotizing fasciitis (Fournier's gangrene), one patient died, and six required a colostomy.

Canadian Relevance

This study covers clostridial gas gangrene and necrotizing soft tissue infections, both of which are Health Canada-recognised indications for hyperbaric oxygen therapy.

Study Limitations

The clinical study was retrospective and observational, lacking a control group to directly assess the independent contribution of hyperbaric oxygen therapy.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Infection
Source Pubmed
PubMed ID 7690268
Year Published 1993
Journal Eur J Surg Suppl

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: March 19, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology